Literature DB >> 9729244

No association between Alzheimer plaques and decreased levels of cytochrome oxidase subunit mRNA, a marker of neuronal energy metabolism.

K Hatanpää1, K Chandrasekaran, D R Brady, S I Rapoport.   

Abstract

It has been proposed that neuritic plaques or toxic substances diffusing from them contribute to neurodegeneration in Alzheimer disease. We examined this hypothesis by looking for evidence of decreased neuronal energy metabolism in the proximity of neuritic plaques. Levels of mitochondrial DNA-encoded mRNA for subunit III of cytochrome oxidase, a marker of neuronal energy metabolism, were determined in post mortem brain samples. Consistent with earlier results, overall cytochrome oxidase subunit III mRNA levels were decreased in Alzheimer midtemporal cortex compared with controls. However, this reduction did not correlate with plaque density. In Alzheimer brains, cytochrome oxidase subunit III mRNA levels in neurons bearing neurofibrillary tangles were lower than in tangle-free neurons. However, neuronal cell bodies in close proximity of neuritic plaques showed no decrease in cytochrome oxidase subunit III mRNA or total polyadenylated mRNA compared with more distant neurons. Cytochrome oxidase enzyme activity in neuronal processes also showed no local reduction around neuritic plaques. These results suggest that neuritic plaques do not contribute to reduced neuronal energy metabolism in Alzheimer disease. Copyright 1998 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9729244     DOI: 10.1016/s0169-328x(98)00117-x

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  10 in total

Review 1.  Brain fuel metabolism, aging, and Alzheimer's disease.

Authors:  Stephen Cunnane; Scott Nugent; Maggie Roy; Alexandre Courchesne-Loyer; Etienne Croteau; Sébastien Tremblay; Alex Castellano; Fabien Pifferi; Christian Bocti; Nancy Paquet; Hadi Begdouri; M'hamed Bentourkia; Eric Turcotte; Michèle Allard; Pascale Barberger-Gateau; Tamas Fulop; Stanley I Rapoport
Journal:  Nutrition       Date:  2010-10-29       Impact factor: 4.008

2.  Biomarkers and evolution in Alzheimer disease.

Authors:  Stanley I Rapoport; Peter T Nelson
Journal:  Prog Neurobiol       Date:  2011-07-23       Impact factor: 11.685

3.  Energy hypometabolism in posterior cingulate cortex of Alzheimer's patients: superficial laminar cytochrome oxidase associated with disease duration.

Authors:  J Valla; J D Berndt; F Gonzalez-Lima
Journal:  J Neurosci       Date:  2001-07-01       Impact factor: 6.167

Review 4.  Mitochondria, OxPhos, and neurodegeneration: cells are not just running out of gas.

Authors:  Estela Area-Gomez; Cristina Guardia-Laguarta; Eric A Schon; Serge Przedborski
Journal:  J Clin Invest       Date:  2019-01-02       Impact factor: 14.808

5.  Differential expression of oxidative phosphorylation genes in patients with Alzheimer's disease: implications for early mitochondrial dysfunction and oxidative damage.

Authors:  Maria Manczak; Byung S Park; Youngsin Jung; P Hemachandra Reddy
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

Review 6.  Coupled reductions in brain oxidative phosphorylation and synaptic function can be quantified and staged in the course of Alzheimer disease.

Authors:  Stanley I Rapoport
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.978

7.  Mitochondria-specific accumulation of amyloid β induces mitochondrial dysfunction leading to apoptotic cell death.

Authors:  Moon-Yong Cha; Sun-Ho Han; Sung Min Son; Hyun-Seok Hong; Young-Ju Choi; Jayoung Byun; Inhee Mook-Jung
Journal:  PLoS One       Date:  2012-04-13       Impact factor: 3.240

8.  Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells.

Authors:  Hindupur K Anandatheerthavarada; Gopa Biswas; Marie-Anne Robin; Narayan G Avadhani
Journal:  J Cell Biol       Date:  2003-04-14       Impact factor: 10.539

9.  Brain pyrimidine nucleotide synthesis and Alzheimer disease.

Authors:  Alba Pesini; Eldris Iglesias; M Pilar Bayona-Bafaluy; Nuria Garrido-Pérez; Patricia Meade; Paula Gaudó; Irene Jiménez-Salvador; Pol Andrés-Benito; Julio Montoya; Isidro Ferrer; Pedro Pesini; Eduardo Ruiz-Pesini
Journal:  Aging (Albany NY)       Date:  2019-09-27       Impact factor: 5.682

Review 10.  Mitochondrial Dysfunction in Alzheimer's Disease: A Biomarker of the Future?

Authors:  Simon M Bell; Katy Barnes; Matteo De Marco; Pamela J Shaw; Laura Ferraiuolo; Daniel J Blackburn; Annalena Venneri; Heather Mortiboys
Journal:  Biomedicines       Date:  2021-01-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.